Logos Global Management »

Minerva Neurosciences shares owned by Logos Global Management

Quarter-by-quarter ownership of Minerva Neurosciences (NERV) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Minerva Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Minerva Neurosciences held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Minerva Neurosciences by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 3.3M 4.02

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Erasca (ERAS)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Tango Therapeutics (TNGX)
Avidity Biosciences Ord (RNA)
Biogen Idec (BIIB)
Immunovant (IMVT)

View all positions for Logos Global Management

Top funds holding Minerva Neurosciences

Logos Global Management
Ally Bridge Group
Federated Investors
Vanguard Group
Renaissance Technologies
BlackRock
Geode Capital Management
Apella Capital
State Street Corporation
Acadian Asset Management
Rangeley Capital
Royal Bank of Canada
UBS Group
Tower Research Capital
CWM

View all funds holding Minerva Neurosciences